Treating Sleep Apnea in Women Veterans

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT03377452
Collaborator
(none)
212
1
2
51.2
4.1

Study Details

Study Description

Brief Summary

This study is a randomized controlled trial (RCT) to test two sleep apnea education programs for women Veterans newly diagnosed with sleep apnea (SA) who are prescribed positive airway pressure (PAP) therapy. This education program is designed to improve participants' sleep quality and help them to adjust to PAP therapy.

Participants will undergo a sleep and health assessment that will be performed prior to beginning the education program. This assessment includes wearing a wrist actigraph to measure sleep and wake periods for 7 days and nights, and answering questionnaires about sleep habits and health. Participants will be randomly assigned to one of two 6-week education programs provided by a study interventionist. Follow-up sleep and health assessments will be conducted at the end of the 6-week education program and 3-months later. PAP usage data will be collected remotely for 12 months from PAP therapy initiation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral Education Intervention I
  • Behavioral: Behavioral Education Intervention II
N/A

Detailed Description

Sleep disordered breathing (SDB) is associated with significant adverse health consequences including cardiovascular disease, motor vehicle accidents, daytime functional impairments and mortality risk. Although SDB is more common among men than women, it still impacts 17% of women in the general population. [The investigators' preliminary evidence suggests it is even more common among women Veterans who receive VA care.] The recommended first-line therapy for most patients with SDB is positive airway pressure therapy (PAP). Published studies show that women have lower PAP adherence than men, particularly in the US, yet the investigators are not aware of data comparing men and women Veterans. Because women Veterans experience significant sleep disturbance and other consequences of sleep disorders, adjusting to PAP therapy may be quite difficult. To date, studies have not tested interventions specifically designed to improve PAP adherence among women, accounting for important sleep-related and social factors.

This study is a randomized controlled trial (RCT) to test the efficacy of a program combining patient education with behavioral techniques to improve adherence to PAP therapy. Women Veterans 18 years and older, who have received care at the VA Greater Los Angeles Healthcare System, and who have at least 1 risk factor for SDB will be recruited for this study. Screening for sleep apnea will be performed in the participant's home using a WatchPAT device. Both objective (actigraphy) and self-report (questionnaire/diary) sleep measures will be collected, as well as other health-related measures. Participants with an AHI of 5 or higher, and who meet all inclusion/exclusion criteria will be randomized to one of two educational programs.

PAP devices, along with education about SDB and insomnia, will be provided to participants as part of the 6-session intervention. Follow-up assessments will be conducted immediately following the intervention and after 3-months.

Main study outcomes (sleep quality and PAP adherence) will be assessed 3 months after PAP initiation, and PAP adherence will be tracked remotely for 12 months. Data will be analyzed using "intention to treat" principles, using appropriate statistical methods for clinical trials.

Study Design

Study Type:
Interventional
Actual Enrollment :
212 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Individuals will be assigned to one of two educational programs simultaneouslyIndividuals will be assigned to one of two educational programs simultaneously
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants and outcome assessors will be blinded to group assignment.
Primary Purpose:
Treatment
Official Title:
Diagnosis and Treatment of Sleep Apnea in Women Veterans
Actual Study Start Date :
Jun 26, 2018
Actual Primary Completion Date :
Mar 31, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral Education Intervention I

Manual-based education program focusing on sleep and sleep apnea provided in individual sessions.

Behavioral: Behavioral Education Intervention I
Manual-based education program focusing on sleep and sleep apnea provided in individual sessions.

Experimental: Behavioral Education Intervention II

Manual-based education program focusing on sleep and sleep apnea provided in individual sessions.

Behavioral: Behavioral Education Intervention II
Manual-based education program focusing on sleep and sleep apnea provided in individual sessions.

Outcome Measures

Primary Outcome Measures

  1. PAP adherence [3 months after PAP initiation]

    Percent of nights with 4 or more hours of PAP use.

  2. sleep quality by patient-reported sleep questionnaire [3 months from randomization]

    Self-reported sleep quality assessed with a brief patient questionnaire assessing multiple aspects of sleep quality.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Community-dwelling women Veterans aged 18 years and older

  • Received care from a VHA facility

  • Have a least one risk factor for sleep apnea (e.g., hypertension, obesity, or age 50 years or older)

  • Diagnosed as having sleep apnea with an AHI of 5 or greater

Exclusion Criteria:
  • Currently using a treatment for sleep apnea

  • Current pregnancy

  • Active substance user or in recovery with < 90 days of sobriety

  • Too ill to engage in study procedures

  • Do not have transportation to the medical center

  • Unable to self-consent (e.g., due to cognitive impairment)

  • Unstable housing

  • Does not have sleep apnea

  • Another sleep disorder (e.g., restless legs syndrome, circadian rhythm sleep disorder) accounts for sleep disturbance

  • No sleep complaints or symptoms

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Greater Los Angeles Healthcare System, Sepulveda, CA Sepulveda California United States 91343

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Jennifer L Martin, PhD, VA Greater Los Angeles Healthcare System, Sepulveda, CA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT03377452
Other Study ID Numbers:
  • IIR 16-244
First Posted:
Dec 19, 2017
Last Update Posted:
Apr 4, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2022